Skip to main
CME
CME logo

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 35 analyst ratings
Hold
Strong Buy 14%
Buy 23%
Hold 46%
Sell 9%
Strong Sell 9%

Bulls say

CME Group has demonstrated a robust financial performance, highlighted by a recent quarterly dividend increase to $1.25, reflecting a year-over-year growth of approximately 9%, supported by consistent free cash flow generation. The company experienced significant growth in its trading volumes, with notable advancements in Henry Hub Natural Gas futures and options, alongside impressive gains in both equity and crypto products, such as a nearly 307% year-over-year increase in crypto average daily volume. Additionally, sustained product innovation and heightened customer demand have driven an increase of around 2.8 million average daily volume, resulting in a revenue generation of approximately $254 million over the past five years, positioning CME Group favorably for continued growth into 2025.

Bears say

The CME Group is currently facing challenges, particularly in its agricultural commodities segment, where a decline in average daily volume was noted due to improved weather conditions in South America expected to yield record soybean production. In a downside scenario analysis, a projected 10% decrease in earnings per share for FY26, coupled with a 20x price-to-earnings multiple, suggests potential valuation risks for CME's stock. Furthermore, the market data and information services revenue, while slightly exceeding estimates, may not be sufficient to offset the overall pressures on open interest and trading volumes, which could deteriorate investor sentiment and financial stability for the company.

CME Group (CME) has been analyzed by 35 analysts, with a consensus rating of Hold. 14% of analysts recommend a Strong Buy, 23% recommend Buy, 46% suggest Holding, 9% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 35 analysts, CME Group (CME) has a Hold consensus rating as of Jul 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $213.46, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $213.46, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.